57/100B423.40
USD
-5.65
(-1.31%)
Market Open
Last updated: · Delayed 15 min
Fair value401.93Plus+5%262Price 423.40501
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Elevance Health price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
Elevance Health's P/S ratio is 0.45: its market cap of 91.48B USD over revenue of 201.83B USD in the last twelve months.
- Today
- 0.45
- Average, 5 years
- 0.57
- Low, 5 years
- 0.31
- High, 5 years
- 0.91
P/S ratio = market cap ÷ revenue (last 12 months) = 91.48B ÷ 201.83B = 0.45
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 0.45 | 91.48B | 201.83B | |
| FY2025 | 31 Dec 2025 | 0.39 | 77.75B | 199.13B |
| FY2024 | 31 Dec 2024 | 0.49 | 85.90B | 176.81B |
| FY2023 | 31 Dec 2023 | 0.64 | 109.91B | 171.34B |
| FY2022 | 31 Dec 2022 | 0.79 | 123.11B | 156.60B |
| FY2021 | 31 Dec 2021 | 0.82 | 113.01B | 138.64B |
| FY2020 | 31 Dec 2020 | 0.66 | 80.53B | 121.87B |
| FY2019 | 31 Dec 2019 | 0.74 | 77.17B | 104.21B |
| FY2018 | 31 Dec 2018 | 0.73 | 66.79B | 92.11B |
| FY2017 | 31 Dec 2017 | 0.64 | 57.62B | 90.04B |
| FY2016 | 31 Dec 2016 | 0.45 | 37.92B | 84.98B |
| FY2015 | 31 Dec 2015 | 0.46 | 36.43B | 79.24B |
| FY2014 | 31 Dec 2014 | 0.46 | 33.69B | 73.92B |
| FY2013 | 31 Dec 2013 | 0.38 | 27.10B | 71.12B |
| FY2012 | 31 Dec 2012 | 0.30 | 18.56B | 61.54B |
| FY2011 | 31 Dec 2011 | 0.37 | 22.48B | 60.80B |
| FY2010 | 31 Dec 2010 | 0.37 | 21.48B | 58.84B |
| FY2009 | 31 Dec 2009 | 0.46 | 28.17B | 61.64B |
| FY2008 | 31 Dec 2008 | 0.35 | 22.09B | 62.46B |
| FY2007 | 31 Dec 2007 | 0.85 | 52.06B | 61.39B |
| FY2006 | 31 Dec 2006 | 0.87 | 49.40B | 57.01B |
| FY2005 | 31 Dec 2005 | 1.08 | 48.78B | 45.15B |
| FY2004 | 31 Dec 2004 | 0.76 | 15.90B | 20.82B |
| FY2003 | 31 Dec 2003 | 0.62 | 10.37B | 16.75B |
| FY2002 | 31 Dec 2002 | 0.56 | 7.48B | 13.26B |
| FY2001 | 31 Dec 2001 | 0.49 | 5.12B | 10.44B |
| FY2000 | 31 Dec 2000 | 0.24 | 4.22B | 17.31B |
| FY1999 | 31 Dec 1999 | 0.34 | 4.22B | 12.35B |
| FY1998 | 31 Dec 1998 | 0.38 | 4.22B | 11.07B |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.42 | 84.61B | 201.83B |
| Q2 FY2026 | 30 Jun 2026 | 0.42 | 84.27B | 201.11B |
| Q1 FY2026 | 31 Mar 2026 | 0.32 | 64.52B | 200.42B |
| Q4 FY2025 | 31 Dec 2025 | 0.39 | 77.75B | 199.13B |
| Q3 FY2025 | 30 Sept 2025 | 0.37 | 72.96B | 194.82B |
| Q2 FY2025 | 30 Jun 2025 | 0.46 | 87.83B | 189.25B |
| Q1 FY2025 | 31 Mar 2025 | 0.54 | 98.47B | 183.12B |
| Q4 FY2024 | 31 Dec 2024 | 0.47 | 83.92B | 176.81B |
| Q3 FY2024 | 30 Sept 2024 | 0.70 | 121.17B | 174.02B |
| Q2 FY2024 | 30 Jun 2024 | 0.72 | 124.12B | 171.72B |
| Q1 FY2024 | 31 Mar 2024 | 0.70 | 120.07B | 171.75B |
| Q4 FY2023 | 31 Dec 2023 | 0.64 | 109.91B | 171.34B |
| Q3 FY2023 | 30 Sept 2023 | 0.61 | 102.45B | 168.62B |
| Q2 FY2023 | 30 Jun 2023 | 0.63 | 105.12B | 165.71B |
| Q1 FY2023 | 31 Mar 2023 | 0.68 | 109.20B | 160.67B |
| Q4 FY2022 | 31 Dec 2022 | 0.78 | 122.07B | 156.60B |
| Q3 FY2022 | 30 Sept 2022 | 0.71 | 108.84B | 153.25B |
| Q2 FY2022 | 30 Jun 2022 | 0.78 | 116.16B | 149.13B |
| Q1 FY2022 | 31 Mar 2022 | 0.82 | 118.58B | 144.35B |
| Q4 FY2021 | 31 Dec 2021 | 0.81 | 112.07B | 138.64B |
| Q3 FY2021 | 30 Sept 2021 | 0.68 | 90.74B | 133.88B |
| Q2 FY2021 | 30 Jun 2021 | 0.72 | 93.35B | 129.22B |
| Q1 FY2021 | 31 Mar 2021 | 0.71 | 87.94B | 124.63B |
| Q4 FY2020 | 31 Dec 2020 | 0.65 | 78.80B | 121.87B |
| Q3 FY2020 | 30 Sept 2020 | 0.57 | 67.42B | 117.45B |
| Q2 FY2020 | 30 Jun 2020 | 0.59 | 66.32B | 112.97B |
| Q1 FY2020 | 31 Mar 2020 | 0.52 | 57.30B | 109.17B |
| Q4 FY2019 | 31 Dec 2019 | 0.73 | 76.39B | 104.21B |
| Q3 FY2019 | 30 Sept 2019 | 0.61 | 61.27B | 100.18B |
| Q2 FY2019 | 30 Jun 2019 | 0.75 | 72.57B | 96.76B |
| Q1 FY2019 | 31 Mar 2019 | 0.79 | 74.13B | 94.23B |
| Q4 FY2018 | 31 Dec 2018 | 0.73 | 67.59B | 92.11B |
| Q3 FY2018 | 30 Sept 2018 | 0.78 | 71.67B | 91.41B |
| Q2 FY2018 | 30 Jun 2018 | 0.68 | 61.58B | 90.59B |
| Q1 FY2018 | 31 Mar 2018 | 0.62 | 56.20B | 90.05B |
| Q4 FY2017 | 31 Dec 2017 | 0.64 | 57.62B | 90.04B |
| Q3 FY2017 | 30 Sept 2017 | 0.55 | 48.88B | 89.09B |
| Q2 FY2017 | 30 Jun 2017 | 0.57 | 49.78B | 88.07B |
| Q1 FY2017 | 31 Mar 2017 | 0.50 | 43.73B | 87.12B |
| Q4 FY2016 | 31 Dec 2016 | 0.45 | 37.92B | 84.89B |
| Q3 FY2016 | 30 Sept 2016 | 0.40 | 32.98B | 83.35B |
| Q2 FY2016 | 30 Jun 2016 | 0.42 | 34.54B | 81.83B |
| Q1 FY2016 | 31 Mar 2016 | 0.45 | 36.53B | 80.39B |
| Q4 FY2015 | 31 Dec 2015 | 0.46 | 36.43B | 79.16B |
| Q3 FY2015 | 30 Sept 2015 | 0.47 | 36.58B | 77.95B |
| Q2 FY2015 | 30 Jun 2015 | 0.56 | 43.19B | 76.61B |
| Q1 FY2015 | 31 Mar 2015 | 0.55 | 41.17B | 75.07B |
| Q4 FY2014 | 31 Dec 2014 | 0.45 | 33.50B | 73.87B |
| Q3 FY2014 | 30 Sept 2014 | 0.45 | 32.36B | 72.46B |
| Q2 FY2014 | 30 Jun 2014 | 0.41 | 29.54B | 71.76B |
| Q1 FY2014 | 31 Mar 2014 | 0.40 | 28.06B | 70.98B |
| Q4 FY2013 | 31 Dec 2013 | 0.37 | 26.05B | 70.69B |
| Q3 FY2013 | 30 Sept 2013 | 0.36 | 24.76B | 68.66B |
| Q2 FY2013 | 30 Jun 2013 | 0.37 | 24.45B | 66.16B |
| Q1 FY2013 | 31 Mar 2013 | 0.32 | 20.45B | 63.87B |
| Q4 FY2012 | 31 Dec 2012 | 0.30 | 18.47B | 61.71B |
| Q3 FY2012 | 30 Sept 2012 | 0.30 | 18.21B | 61.49B |
| Q2 FY2012 | 30 Jun 2012 | 0.34 | 20.90B | 61.54B |
| Q1 FY2012 | 31 Mar 2012 | 0.40 | 24.49B | 61.23B |
| Q4 FY2011 | 31 Dec 2011 | 0.36 | 21.98B | 60.71B |
| Q3 FY2011 | 30 Sept 2011 | 0.39 | 23.24B | 60.04B |
| Q2 FY2011 | 30 Jun 2011 | 0.49 | 28.84B | 59.22B |
| Q1 FY2011 | 31 Mar 2011 | 0.44 | 25.73B | 58.55B |
| Q4 FY2010 | 31 Dec 2010 | 0.36 | 20.96B | 58.72B |
| Q3 FY2010 | 30 Sept 2010 | 0.35 | 22.36B | 63.12B |
| Q2 FY2010 | 30 Jun 2010 | 0.34 | 21.58B | 63.98B |
| Q1 FY2010 | 31 Mar 2010 | 0.44 | 28.40B | 64.96B |
| Q4 FY2009 | 31 Dec 2009 | 0.40 | 25.71B | 65.03B |
| Q3 FY2009 | 30 Sept 2009 | 0.37 | 22.33B | 61.05B |
| Q2 FY2009 | 30 Jun 2009 | 0.42 | 25.24B | 60.59B |
| Q1 FY2009 | 31 Mar 2009 | 0.31 | 18.83B | 60.84B |
| Q4 FY2008 | 31 Dec 2008 | 0.34 | 20.90B | 61.25B |
| Q3 FY2008 | 30 Sept 2008 | 0.39 | 24.02B | 61.74B |
| Q2 FY2008 | 30 Jun 2008 | 0.40 | 24.77B | 62.02B |
| Q1 FY2008 | 31 Mar 2008 | 0.39 | 23.95B | 61.63B |
| Q4 FY2007 | 31 Dec 2007 | 0.78 | 47.77B | 61.16B |
| Q3 FY2007 | 30 Sept 2007 | 0.77 | 46.56B | 60.15B |
| Q2 FY2007 | 30 Jun 2007 | 0.82 | 48.67B | 59.36B |
| Q1 FY2007 | 31 Mar 2007 | 0.85 | 49.62B | 58.26B |
| Q4 FY2006 | 31 Dec 2006 | 0.84 | 48.14B | 57.01B |
| Q3 FY2006 | 30 Sept 2006 | 0.88 | 47.69B | 53.89B |
| Q2 FY2006 | 30 Jun 2006 | 0.90 | 45.55B | 50.60B |
| Q1 FY2006 | 31 Mar 2006 | 1.06 | 50.59B | 47.58B |
| Q4 FY2005 | 31 Dec 2005 | 1.17 | 52.13B | 44.68B |
| Q3 FY2005 | 30 Sept 2005 | 1.15 | 46.26B | 40.08B |
| Q2 FY2005 | 30 Jun 2005 | 1.26 | 42.34B | 33.73B |
| Q1 FY2005 | 31 Mar 2005 | 1.40 | 37.96B | 27.19B |
| Q4 FY2004 | 31 Dec 2004 | 1.69 | 35.22B | 20.82B |
| Q3 FY2004 | 30 Sept 2004 | 0.66 | 12.14B | 18.28B |
| Q2 FY2004 | 30 Jun 2004 | 0.70 | 12.39B | 17.74B |
| Q1 FY2004 | 31 Mar 2004 | 0.73 | 12.55B | 17.24B |
| Q4 FY2003 | 31 Dec 2003 | 0.62 | 10.36B | 16.77B |
| Q3 FY2003 | 30 Sept 2003 | 0.60 | 9.87B | 16.47B |
| Q2 FY2003 | 30 Jun 2003 | 0.68 | 10.69B | 15.78B |
| Q1 FY2003 | 31 Mar 2003 | 0.63 | 9.20B | 14.57B |
| Q4 FY2002 | 31 Dec 2002 | 0.66 | 8.74B | 13.28B |
| Q3 FY2002 | 30 Sept 2002 | 0.70 | 8.37B | 11.95B |
| Q2 FY2002 | 30 Jun 2002 | 0.60 | 6.63B | 11.04B |
| Q1 FY2002 | 31 Mar 2002 | — | 6.02B | — |
| Q4 FY2001 | 31 Dec 2001 | — | 5.09B | — |
| Q3 FY2001 | 30 Sept 2001 | — | 4.22B | — |
| Q1 FY2001 | 31 Mar 2001 | — | 0.00 | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Elevance Health's P/S ratio
Source: Financial Modeling Prep